In a patient with simple premature ventricular contractions (PVCs) and premature atrial contractions (PACs), which muscle relaxant should be avoided and what are the recommended alternative agents and dosing?

Muscle Relaxants in Patients with Simple PVCs and PACs

In patients with simple premature ventricular contractions (PVCs) and premature atrial contractions (PACs), there are no specific muscle relaxant contraindications based on the presence of these benign arrhythmias alone.

Key Clinical Context

The provided evidence focuses extensively on management of atrial fibrillation, supraventricular tachycardia, and pathologic ventricular arrhythmias—not simple, isolated PVCs and PACs. This distinction is critical.

Understanding "Simple" PVCs and PACs

Simple PVCs and PACs refer to:

• Infrequent ectopic beats (typically <10% burden)
• Asymptomatic or minimally symptomatic
• No underlying structural heart disease
• No hemodynamic compromise
• No associated cardiomyopathy

These benign arrhythmias are extremely common in the general population and do not require treatment in most cases 1, 2, 3.

Muscle Relaxant Considerations

No Specific Contraindications for Simple Ectopy

Standard neuromuscular blocking agents (rocuronium, vecuronium, cisatracurium, atracurium) can be safely used in patients with simple PVCs and PACs. The presence of occasional ectopic beats does not alter muscle relaxant selection in the absence of:

• Hemodynamic instability
• Structural heart disease
• Significant arrhythmia burden
• Pre-excitation syndromes (WPW)
• Cardiomyopathy

Succinylcholine Considerations

While succinylcholine can theoretically increase vagal tone and cause bradycardia or nodal rhythms, simple PVCs and PACs are not contraindications to its use. The primary concerns with succinylcholine relate to:

• Hyperkalemia risk conditions
• Malignant hyperthermia susceptibility
• Neuromuscular disorders

When to Exercise Caution

Reassess the clinical picture if:

1. High PVC burden (>10-20%): May indicate PVC-induced cardiomyopathy risk 4, 2, 5
2. Symptomatic arrhythmias: Palpitations, presyncope, dyspnea suggest more significant disease 1, 2
3. Structural heart disease present: Changes risk stratification entirely
4. Multifocal or complex PVCs: May indicate underlying pathology 6

Recommended Approach

Preoperative Assessment Algorithm

1. Verify "simple" designation:

   • Review recent ECG and Holter monitoring
   • Confirm PVC/PAC burden <10%
   • Ensure normal echocardiogram if available
   • Rule out symptoms (palpitations, syncope, dyspnea)

2. Screen for structural disease:

   • History of heart failure, cardiomyopathy, or coronary disease
   • Physical exam findings of cardiac dysfunction
   • ECG evidence of ischemia, hypertrophy, or conduction disease

3. If truly simple PVCs/PACs with normal cardiac function:

   • Proceed with standard anesthetic management
   • No muscle relaxant restrictions
   • Use any neuromuscular blocking agent appropriate for the surgical procedure

Intraoperative Management

• Standard hemodynamic monitoring
• Avoid excessive sympathetic stimulation (adequate anesthetic depth)
• Maintain normal electrolytes (particularly potassium and magnesium)
• Treat new sustained arrhythmias if they develop, but isolated ectopy requires no intervention

Common Pitfalls to Avoid

1. Over-treating benign ectopy: Simple PVCs/PACs do not require antiarrhythmic therapy 7, 2

2. Confusing simple ectopy with pathologic arrhythmias: The guidelines extensively discuss treatment of sustained arrhythmias, pre-excited AF, and high-burden PVCs—these are different clinical entities 8, 9, 10

3. Unnecessary medication avoidance: No evidence supports avoiding specific muscle relaxants in patients with simple, benign ectopy

4. Failing to investigate new or worsening ectopy: If PVC burden increases significantly (>20%), consider evaluation for PVC-induced cardiomyopathy 4, 5

Medical Therapy Context (If Treatment Were Needed)

Should these patients require arrhythmia treatment postoperatively (which is uncommon for simple ectopy):

• First-line for symptomatic PVCs: Beta-blockers or nondihydropyridine calcium channel blockers 1, 2, 11
• Avoid routine antiarrhythmic use: Not justified for asymptomatic premature complexes 7
• Consider trazodone cautiously: Use with caution in patients with PVCs if needed for other indications 12

The key message: Simple PVCs and PACs represent normal variant findings in most patients and do not dictate muscle relaxant choice in the perioperative setting.